Arkolith/Insider Trading/SCPH/Form 4

Tucker John H

President and CEO, DirectorscPharmaceuticals Inc. (SCPH) · full profile →Form 4 · filed Oct 11, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 7, 2022Tax withholding(F)10K$4.98$51K79K
Oct 7, 2022Option exercise(M)42K——89K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 7, 2022Grant(A)42K—$042K
Oct 7, 2022Option exercise(M)42K—$00

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-033404) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML